Heart Failure
-
Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.
Load moreHeart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.
The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.
Load Less
Videos
-
20 March 2020
-
25 June 2020
-
20 April 2020
-
14 April 2020
-
28 January 2020
-
06 January 2020
Pages
Webinars
-
Yvonne Millerick, Jayne Masters, Charlie Bloe, Aysha Mendes
-
Antoni Bayés-GenísEuropean Cardiology Review 2020;15:e17.DOI: https://doi.org/10.15420/ecr.2020.03
-
Ferdinando Iellamo, Barbara Sposato, Maurizio Volterrani, et alCardiac Failure Review 2020;6:e07.DOI: https://doi.org/10.15420/cfr.2019.20
-
Ivo Planinc, Davor Milicic, Maja Cikes, et alCardiac Failure Review 2020;6:e06.DOI: https://doi.org/10.15420/cfr.2019.12
-
Sriram D Rao, Srinath Adusumalli, Jeremy A Mazurek, et alCardiac Failure Review 2020;6:e05.DOI: https://doi.org/10.15420/cfr.2019.09
